Stock of the Day

Ascendis Pharma A/S (ASND)

$152.43

-$2.15 (-1.4%)

Market Cap: $9.38B

About Ascendis Pharma A/S

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.

The company was incorporated in 2006 and is headquartered in Hellerup, Denmark.

Recent News

• Ascendis Pharma price target raised to $180 from $175 at Morgan Stanley (markets.businessinsider.com)